Thailand marked a major advancement in the global stem cell treatment landscape today with the signing of a landmark Memorandum of Understanding (MoU) involving leading research institutions, hospitals, and biotech companies from both Thailand and Singapore. This agreement centers on the development of cutting-edge mesenchymal stem cell (MSC) therapies aimed at treating solid tumors and other medical conditions. The collaboration reinforces Thailand’s role as a premier hub for regenerative medicine and medical tourism in the region.
Key Signatories and Stakeholders in Stem Cell Collaboration
- Dr. Supamas Isarabhakdi, Minister of Higher Education, Science, Research and Innovation (Thailand)
- Dr. Chutima Eamchotchawalit, Governor, Thailand Institute of Scientific and Technological Research (TISTR)
- Dr. Sranyoo Chanate, CEO, Kluaynamthai Hospital
- Dr. Sarah Ho, Co-founder, AGeM Bio (Singapore)
- Mr. Nattapop Bhuridej, Chairman, Vega Group Thailand
The MoU was signed between the following key organizations involved in stem cell research and advanced therapy development:
• Thailand Institute of Scientific and Technological Research (TISTR)
• Kluaynamthai Hospital (KNT)
• AGeM Bio Pte Ltd, Singapore
• Vega Wellness Co., Ltd., Thailand
Advancing Stem Cell Treatments and Regenerative Medicine in Thailand
The aim of this international collaboration is to research, develop, and commercialize engineered mesenchymal stem cell (MSC) therapies targeting a variety of clinical conditions, with a particular focus on cancer, especially solid tumors. This initiative aligns with the rising demand for personalized medicine, biologic treatments, and cutting-edge regenerative therapies.
Areas of Cooperation in the Global Stem Cell Ecosystem
The MoU specifies the following key areas of collaboration to fast-track the development and implementation of advanced cell therapy solutions:
- Joint scientific research focused on mesenchymal stem cell therapy applications
- Clinical trials and patient-centered studies to evaluate safety and effectiveness
- Exchange of knowledge and data between Thai and Singaporean institutions
- Collaborative publications and grant proposals targeting high-impact international research
- Training programs, educational initiatives, and academic workshops for healthcare professionals and researchers
A Medical Tourism Milestone: Thailand as a Global Stem Cell Hub
Thailand has long been recognized for its excellence in medical tourism and cosmetic surgery. This MoU further strengthens the country’s position as a leading destination for biotechnology and stem cell therapy, offering international patients access to high-quality, scientifically backed, and cost-effective regenerative treatments.
Legal and Commercial Framework for Advanced Therapies
While the MoU is non-binding in its overall scope, it contains legally binding provisions related to intellectual property (IP), confidentiality, and data protection. Each research and clinical initiative under the collaboration will be governed by individual Project Agreements, all of which will be subject to regulatory review and adherence to clinical trial ethics.
The agreement is set to remain in effect for an initial term of three years, with provisions for renewal and potential expansion into additional advanced therapeutic platforms in the future.
Future of Stem Cell Medicine in Southeast Asia
This strategic partnership is part of a larger regional effort to position Southeast Asia—particularly Thailand—as a hub for stem cell innovation, biotech manufacturing, and medical exports. The collaborating institutions are united in their commitment to establishing Thailand as a key player in the rapidly growing global regenerative medicine market, which is projected to surpass USD 150 billion by 2030.
About Vega Stem Cell
Vega Stem Cell is a Bangkok-based clinic specializing in stem cell treatments and regenerative medicine. Committed to clinical excellence, its mission is to provide safe, effective, and scientifically supported stem cell therapies for managing chronic illnesses, promoting healthy aging, and supporting tissue repair and regeneration.
Contact Information
Vega Medical Services
3/6, The Primary 101, Soi Lad Phrao 101
Lad Phrao Road, Khlong Chan
Bang Kapi District, Bangkok 10240
Thailand
Email: vegastemcell@gmail.com
Tel & WhatsApp: +66 (0) 86 691 6915
Website: www.vegastemcell.com